This topic contains a solution. Click here to go to the answer

Author Question: What ethical obligation would a researcher studying treatment approaches have to address? A) Both ... (Read 58 times)

Lisaclaire

  • Hero Member
  • *****
  • Posts: 569
What ethical obligation would a researcher studying treatment approaches have to address?
 
  A) Both the treatment and control groups should be given the choice of what treatment they want to have.
  B) If the treatment proves effective, the control group should be given the choice of whether they want the treatment.
  C) If the treatment proves ineffective, the control group should be given the choice of whether they want the treatment.
  D) The control group should be given a choice of treatment, but the experimental groups would not get that choice.

Question 2

What is the best way for researchers deal with the ethical problem raised by randomly assigning some participants to a no-treatment control group?
 
  A) by including only a treatment group with no control group
  B) by not telling participants that they might be in a no-treatment group
  C) by allowing participants to decide which group they would like to be assigned to
  D) by obtaining informed consent from participants who are told that they may be assigned to a no-treatment condition



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aprice35067

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Answer: B

Answer to Question 2

Answer: D




Lisaclaire

  • Member
  • Posts: 569
Reply 2 on: Aug 4, 2018
YES! Correct, THANKS for helping me on my review


kishoreddi

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library